Ceuticoz, a well-known Indian dermatology-led cosmeceutical brand, is now in the baby care market with Ceuticoz Baby, a science-based skincare line for newborns. This move expands the brand’s offerings and places it among the startups in India that are pushing for clinical, evidence-based personal care items.
Ceuticoz is known for its strength in dermatology, trichology, and professional skincare in India’s Direct-to-Consumer(D2C) space. With Ceuticoz Baby, the brand brings its over 20 years of dermatological experience to baby skincare. This area is seeing more demand as Indian D2C consumers look for transparency, sustainability, and formulations they can trust.
The Ceuticoz Baby line has seven items: Baby Wash & Shampoo, Moisture Cream, Moisturizing Lotion, Comfort Cream, Massage Oil, Barrier Repair Cream, and Sunscreen Lotion. Each item is approved by pediatricians, hypoallergenic, and either fragrance-free or certified by the International Fragrance Association(IFRA). They don’t have Sodium lauryl sulfate(SLS)/Sodium laureth sulfate(SLES), mineral oils, silicones, parabens, sulphates, or phthalates. The products moisturize for up to 24 hours, keep a pH of 5.5, and are clinically tested to be compatible with newborn skin, showing Ceuticoz’s priority of research among Indian D2C personal care brands.
This launch is part of D2C market trends where premium brands are entering high-trust, specialty areas like baby skincare, dermatology, and wellness. Ceuticoz plans to grow its D2C approach by selling Ceuticoz Baby in hospitals, dermatology clinics, pediatric centers, maternity networks, baby stores, and pharmacies. This wider distribution fits with the increasing significance of omnichannel retail, where having a physical presence improves digital awareness.
Ceuticoz has also invested in packaging. The Ceuticoz Baby line uses recyclable, BPA-free bottles with soft textures, offering a comforting experience for parents and aligning the brand with D2C personal care brands that set high standards for packaging and safety in India.
Arvin Mondal, Head of Marketing at Ceuticoz, says the launch is both emotional and scientific:
“A baby’s skin tells you if they’re comfortable even before they can talk. With Ceuticoz Baby, we made skincare that parents can trust from the start — safe, science-backed, and dermatologically tested.”
Sukhbir Singh Chimni, Managing Director, sees this move as the beginning of Ceuticoz’s plan to grow into more categories:
“Evidence-based skincare is important at every age. Ceuticoz Baby is the first step in our global vision for baby care.”
Ceuticoz is planning Phase 2 extensions for scalp and barrier problems, showing its focus on innovation. In the next five years, the company wants to increase its network to 30,000 dermatologists, grow its international sales, and get up to 40% of its revenue from global markets. This shows big plans for D2C expansion and could lead to funding rounds or an IPO.
With the rising need for safe, medically tested baby care, Ceuticoz Baby puts the company among the fastest-growing D2C brands with the ability to shape the next wave of dermatology-led products in India. Its focus on science, innovation, and multi-channel growth gives Ceuticoz a good position in a market where trust and scale are key.
